Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.
about
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironmentRetroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectivesEfficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor model.iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancersSerial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow.Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector.Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease.PEGylated Cationic Serum Albumin for Boosting Retroviral Gene Transfer.New MSC: MSCs as pericytes are Sentinels and gatekeepers.MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation.Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases.A new chemical complex can rapidly concentrate lentivirus and significantly enhance gene transduction.An engineered biomarker system to monitor and modulate immune clearance of cell therapies.Optimized Longitudinal Monitoring of Stem Cell Grafts in Mouse Brain Using a Novel Bioluminescent/Near Infrared Fluorescent Fusion Reporter.miR-483 targets SMAD4 to suppress chondrogenic differentiation of human mesenchymal stem cells.Nondestructive/Noninvasive Imaging Evaluation of Cellular Differentiation Progression During In Vitro Mesenchymal Stem Cell-Derived Chondrogenesis.Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging.Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.
P2860
Q26853374-4FA5DCA0-0124-43CB-B860-C055DAFB2541Q28074002-BF9F77CB-0CC9-4355-A3D9-F97C979B5880Q30420262-978DD46A-BDD2-48F1-936C-6190F3C5D92CQ33458985-62159FF3-0699-4E40-A6E7-4E15F0896FC0Q34997877-6EB109C9-DE98-4CF3-9ABD-78D4679ED922Q37170654-A12F7F28-D0DF-4C6A-A05D-BF942F0937F2Q38599408-ED2F1041-008B-4C02-84A8-05118128BC9AQ38767557-D13077F2-F8D7-451F-A80F-4B20D8625B08Q39179108-B356B907-6910-4F30-AB55-C47BEDD9FF7CQ39356606-EC3BB597-1E05-4C38-A846-3E227FBC2238Q40047893-C7144379-B112-480E-B5AD-7A8FA54133FCQ40051647-1B71BFD9-D156-4816-B18E-1B8825C9A550Q47667916-E2E80606-ED5D-480D-BDAD-32AC18FBF01EQ47825737-A90976D5-1957-4B82-95D7-94439F24F01CQ48186071-C83D51CB-7673-4E75-B33A-A44AEE820AE2Q50499555-FCEECF4F-A9B1-4437-A65F-0D6B4BE8E870Q52628020-7D404351-D23B-45F1-BDBA-120BCAFBE90FQ53705286-FF93FEC7-0E0D-4774-B825-944A8DF9417C
P2860
Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Efficient lentiviral transduct ...... differentiation capabilities.
@en
type
label
Efficient lentiviral transduct ...... differentiation capabilities.
@en
prefLabel
Efficient lentiviral transduct ...... differentiation capabilities.
@en
P2093
P2860
P356
P1476
Efficient lentiviral transduct ...... d differentiation capabilities
@en
P2093
Diego Correa
Donald P Lennon
Mark Schluchter
P2860
P304
P356
10.5966/SCTM.2012-0086
P577
2012-11-29T00:00:00Z